Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,044 | 20,421 | 61,661 | 83,293 | 30,706 |
| Marketable Securities | 194,645 | 241,851 | 249,127 | 113,524 | 200,481 |
| Receivables | 4,406 | 4,482 | 4,825 | 10,597 | 5,014 |
| Inventories | 2,142 | 2,112 | 1,948 | 2,149 | 811 |
| TOTAL | $220,191 | $273,150 | $321,995 | $214,021 | $247,186 |
| Non-Current Assets | |||||
| PPE Net | 16,772 | 17,244 | 17,687 | 18,167 | 18,588 |
| Intangibles | 95,545 | 95,987 | 96,428 | 96,870 | 97,311 |
| Other Non-Current Assets | 429 | 432 | 429 | 429 | 428 |
| TOTAL | $112,746 | $113,663 | $114,544 | $115,466 | $116,327 |
| Total Assets | $332,937 | $386,813 | $436,539 | $329,487 | $363,513 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,896 | 13,517 | 14,094 | N/A | 15,156 |
| Accounts payable and accrued liabilities | 50,451 | 66,553 | 38,762 | 52,628 | 43,857 |
| Accrued Expenses | 12,865 | 12,863 | 12,282 | 12,729 | 10,959 |
| TOTAL | $81,336 | $100,370 | $105,489 | $128,728 | $133,173 |
| Non-Current Liabilities | |||||
| Long Term Debt | 232,198 | 231,879 | 231,576 | 85,512 | 85,383 |
| Deferred Revenues | 5,124 | 7,437 | 40,351 | 48,738 | 63,201 |
| Other Non-Current Liabilities | 265 | 279 | 292 | 303 | 313 |
| TOTAL | $256,672 | $260,249 | $262,785 | $122,383 | $124,027 |
| Total Liabilities | $338,008 | $360,619 | $368,274 | $251,111 | $257,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 105,879 | 105,832 | 105,592 | 105,588 | 105,582 |
| Common Shares | 106 | 106 | 106 | 106 | 105 |
| Retained earnings | -1,443,973 | -1,409,267 | -1,365,241 | -1,353,026 | -1,322,304 |
| Other shareholders' equity | -94 | -270 | -126 | 33 | -118 |
| TOTAL | $-5,071 | $26,194 | $68,265 | $78,376 | $106,313 |
| Total Liabilities And Equity | $332,937 | $386,813 | $436,539 | $329,487 | $363,513 |